These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 313692)

  • 1. Virus spike protein complexes and virosomes as effective subunit vaccines.
    Morein B; Helenius A; Simons K; Schirrmacher V
    Adv Exp Med Biol; 1979; 114():811-6. PubMed ID: 313692
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J; Helenius A; Simons K
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles for production of effective defined subunit vaccines. Deduction from a model experiment.
    Morein B; Helenius A; Simons K
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):201-6. PubMed ID: 6258847
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective subunit vaccines against an enveloped animal virus.
    Morein B; Helenius A; Simons K; Pettersson R; Kääriäinen L; Schirrmacher V
    Nature; 1978 Dec; 276(5689):715-8. PubMed ID: 310517
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of effective subunit vaccines against enveloped viruses.
    Simons K; Helenius A; Morein B; Balcorova J; Sharp M
    Prog Clin Biol Res; 1980; 47():217-28. PubMed ID: 6259665
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.
    de Mare A; Lambeck AJ; Regts J; van Dam GM; Nijman HW; Snippe H; Wilschut J; Daemen T
    Gene Ther; 2008 Mar; 15(6):393-403. PubMed ID: 18004406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross protection among togaviruses in nude mice and littermates.
    Latif Z; Gates D; Wust CJ; Brown A
    J Gen Virol; 1979 Oct; 45(1):89-98. PubMed ID: 316446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
    Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
    Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA; Benaissa-Trouw BJ; Harmsen M; Kraaijeveld CA; Snippe H
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Ekstijn GL; Kraaijeveld CA; Snippe H
    Immunology; 1992 Feb; 75(2):224-31. PubMed ID: 1551685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immunity against Semliki Forest virus in mice.
    Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B
    Infect Immun; 1979 Feb; 23(2):213-8. PubMed ID: 311341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of N-acetylethyleneimine [AEI] for the inactivation of Semliki Forest virus in vitro.
    Amor S; Webb HE
    J Med Virol; 1986 Aug; 19(4):367-76. PubMed ID: 3746260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique immunomodulating properties of dimethyl dioctadecyl ammonium bromide (DDA) in experimental viral vaccines.
    Katz D; Lehrer S; Galan O; Lachmi B; Cohen S; Inbar I; Samina I; Peleg B; Heller D; Yadin H; Chai D; Freeman E; Schupper H; Fuchs P
    Adv Exp Med Biol; 1996; 397():115-25. PubMed ID: 8718590
    [No Abstract]   [Full Text] [Related]  

  • 15. The responses of normal an athymic mice to infections by togaviruses: strain differentiation in active and adoptive immunization.
    Bradish CJ; Fitzgeorge R; Titmuss D
    J Gen Virol; 1980 Feb; 46(2):255-65. PubMed ID: 6966674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alphavirus hybrid virion vaccines.
    Shafferman A; Lustig S; Inbar Y; Halevy M; Schneider P; Bino T; Leitner M; Grosfeld H; Velan B; Schödel F; Cohen S
    Adv Exp Med Biol; 1996; 397():41-7. PubMed ID: 8718580
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.
    Hidmark AS; Nordström EK; Dosenovic P; Forsell MN; Liljeström P; Karlsson Hedestam GB
    J Virol; 2006 Jul; 80(14):7100-10. PubMed ID: 16809315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus.
    Chen M; Hu KF; Rozell B; Orvell C; Morein B; Liljeström P
    J Immunol; 2002 Sep; 169(6):3208-16. PubMed ID: 12218139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.